News

October 17, 2011 — The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has become the first cardiac care facility in Michigan to successfully open a patient's blocked artery with a...

August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in the Peripheral Facilitated Antegrade Steering Technique in Chronic Total...

February 16, 2011 – To expand its portfolio of devices for lower extremity peripheral artery disease (PAD), Boston Scientific this week acquired two new technologies to treat chronic total...

January 25, 2011 – A microcatheter offering superior crossability, flexibility and guidewire support during coronary and peripheral catheterization procedures was released this week by Vascular...

October 5, 2010 – A U.S. clinical study evaluating the CrossBoss and Stingray catheters in treating chronically occluded coronary arteries concluded in August and Bridgepoint Medical has asked the...

November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO...

November 10, 2009 – The latest data from seven studies focused on the treatment of peripheral arterial disease (PAD) were presented in the late-breaking trials session of the Vascular...

October 22, 2009 – FlowCardia Inc. yesterday began its U.S. launch of the over the wire (OTW) delivery platform for the CROSSER 14S and CROSSER 14P peripheral chronic total occlusions (CTOs)...

October 21, 2009 – Cook Medical is introducing six new products in parallel to provide better treatment options to treat peripheral arterial disease (PAD), including new microwires, stents and...

October 7, 2009 – FlowCardia Inc. this week launched the FlowMate Injector, which dramatically simplifies central lumen crossing of chronic total occlusions (CTOs) using the CROSSER CTO...

August 11, 2009 – Pathway Medical Technologies Inc. today introduced the 7 French compatible version of its peripheral atherectomy catheter, the Jetstream G2 NXT.

March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO Catheter and Stingray CTO Re-Entry System.